Evidence map›Paper›PMID 38886098›Full record

ReviewPhysiological reports2024

Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health.

Mrunmayee R Kandalgaonkar, Virender Kumar, Matam Vijay-Kumar

Abstract readReview
In one paragraph

Review in Physiological reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mrunmayee R KandalgaonkarDepartment of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.ORCID 0000-0002-5560-7825
Virender KumarCollege of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.
Matam Vijay-KumarDepartment of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.ORCID 0000-0002-8732-0167

Funding

Role of neutrophil extracellular traps (NETs) in Inflammatory bowel diseaseR01DK134053 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MATAM VIJAY-KUMAR · 2023 to 2026
$1.7M
Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular CarcinomaR01CA219144 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI VIJAY-KUMAR, MATAM · 2017 to 2021
$1.6M
Targeting PI3K/BRD4 and Hedgehog Pathway in Alcohol Associated Liver DiseaseK01AA029763 · NIAAA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KUMAR, VIRENDER · 2021 to 2025
$528k
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver DiseaseR21AA029767 · NIAAA · UNIVERSITY OF TOLEDO · PI KUMAR, VIRENDER · 2023 to 2023
$390k
HHS | NIH | NCI | Basic Research Laboratory (BRL) CA219144HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) DK134053NCI NIH HHS R01 CA219144NIAAA NIH HHS K01 AA029763NIAAA NIH HHS R21 AA029767NIDDK NIH HHS R01 DK134053
6 · The paper itself

Abstract

Although the liver is the largest metabolic organ in the body, it is not alone in functionality and is assisted by "an organ inside an organ," the gut microbiota. This review attempts to shed light on the partnership between the liver and the gut microbiota in the metabolism of macronutrients (i.e., proteins, carbohydrates, and lipids). All nutrients absorbed by the small intestines are delivered to the liver for further metabolism. Undigested food that enters the colon is metabolized further by the gut microbiota that produces secondary metabolites, which are absorbed into portal circulation and reach the liver. These microbiota-derived metabolites and co-metabolites include ammonia, hydrogen sulfide, short-chain fatty acids, secondary bile acids, and trimethylamine N-oxide. Further, the liver produces several compounds, such as bile acids that can alter the gut microbial composition, which can in turn influence liver health. This review focuses on the metabolism of these microbiota metabolites and their influence on host physiology. Furthermore, the review briefly delineates the effect of the portosystemic shunt on the gut microbiota-liver axis, and current understanding of the treatments to target the gut microbiota-liver axis.

Indexed as

Gastrointestinal MicrobiomeLiverAnimalsBile Acids and SaltsHumansNutrientsBile Acids and SaltsNutrientsbacterial metabolitesbile acidsbile salt hydrolaseshort‐chain fatty acids

Identifiers

PMID38886098
PMCPMC11182692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.